Lucid Diagnostics Inc. Securities Sold under Agreements to Repurchase, Asset
Lucid Diagnostics Inc. (LUCD) had Securities Sold under Agreements to Repurchase, Asset of $1.00 million as of 2022-03-28, per its 10-K filed 2023-03-14.
Discontinued › Notes
us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseAsset · last filed 2023-03-14
- 2022-03-28: Securities Sold under Agreements to Repurchase, Asset $1.00M.
| Period end | Securities Sold under Agreements to Repurchase, Asset |
|---|---|
| 2022-03-28 | $1.00M 10-K · filed 2023-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |